miRNA Regulation of the FGF23-Klotho Pathway Mitigates Adverse Cardiac Remodeling During Nocturnal Hemodialysis

BACKGROUND: Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in patients with ESKD. Dysregulation of the fibroblast growth factor 23 (FGF23)/Klotho axis has been implicated in uremic cardiomyopathy, however the mechanism linking dialysis intensity to the regulation of this pathway remains poorly defined. METHODS: We analyzed serum samples from ESKD patients transitioning from conventional to nocturnal hemodialysis (NHD). Left ventricular mass (LVM) was measured by echocardiography before and after transition. Patients were stratified as LVM regressors [ ≥ 10% decrease in LVM; n = 6] or LVM progressors [ ≥ 10% increase in LVM; n = 7]. Circulating microRNAs (miRs) and serum FGF23 and alpha Klotho were quantified. Mechanistic relevance was tested in an angiotensin-II model of cardiac hypertrophy using FGF23 suppression via an antisense oligonucleotide gapmer, or antagomirs targeting miR-200c-3p. RESULTS: Among 13 patients transitioning to NHD, LVM regressors required fewer antihypertensive medications than at baseline (P<0.001) with improved metabolic parameters (urea 12.9 vs. 16.6 mmol/L, P<0.01) and higher hemoglobin (109 vs. 95 g/L, P<0.01). We identified six differentially expressed miRs (let-7a/g/i, miR-200c, miR-1 and miR-30c) that targeted the FGF23/Klotho signaling axis. LVM regressors also demonstrated significantly lower circulating FGF23 levels than LVM progressors [60 (28, 160) vs 668 (73, 1734) pg/mL, P<0.05]. In the angiotensin-II murine model of cardiac hypertrophy, FGF23 gapmer treatment or miR-200c-3p inhibition reduced cardiomyocyte hypertrophy and attenuated interstitial fibrosis while restoring FGF23/Klotho signaling through the suppression of extracellular signal-regulated kinase 1/2 phosphorylation, activation of dual specificity phosphatase-1 and inducing antioxidant gene expression. CONCLUSIONS: Collectively, these exploratory findings link dialysis intensification to miR-mediated regulation of the FGF23/Klotho axis, demonstrating that targeting this regulatory network is sufficient to suppress pathological cardiac remodeling. These data provide a mechanistic basis for the cardiovascular benefits of nocturnal hemodialysis and identify the FGF23/Klotho axis as a candidate therapeutic target warranting further validation.

Authors

Institutions

Publication Details

Journal
Clinical Journal of the American Society of Nephrology
Published
2026-11-19
DOI
https://doi.org/10.2215/cjn.0000001264
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

miRNA Regulation of the FGF23-Klotho Pathway Mitigates Adverse Cardiac Remodeling During Nocturnal Hemodialysis

Daniela Grothe, Ludger Hauck, Christopher T. Chan, Filio Billia et al.
Clinical Journal of the American Society of Nephrology
Parathyroid Disorders and Treatments
article

miRNA Regulation of the FGF23-Klotho Pathway Mitigates Adverse Cardiac Remodeling During Nocturnal Hemodialysis

Daniela Grothe, Ludger Hauck, Christopher T. Chan, Filio Billia, Benny Premsingh, Carmine A Alberga
article en

Abstract

BACKGROUND: Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in patients with ESKD. Dysregulation of the fibroblast growth factor 23 (FGF23)/Klotho axis has been implicated in uremic cardiomyopathy, however the mechanism linking dialysis intensity to the regulation of this pathway remains poorly defined. METHODS: We analyzed serum samples from ESKD patients transitioning from conventional to nocturnal hemodialysis (NHD). Left ventricular mass (LVM) was measured by echocardiography before and after transition. Patients were stratified as LVM regressors [ ≥ 10% decrease in LVM; n = 6] or LVM progressors [ ≥ 10% increase in LVM; n = 7]. Circulating microRNAs (miRs) and serum FGF23 and alpha Klotho were quantified. Mechanistic relevance was tested in an angiotensin-II model of cardiac hypertrophy using FGF23 suppression via an antisense oligonucleotide gapmer, or antagomirs targeting miR-200c-3p. RESULTS: Among 13 patients transitioning to NHD, LVM regressors required fewer antihypertensive medications than at baseline (P<0.001) with improved metabolic parameters (urea 12.9 vs. 16.6 mmol/L, P<0.01) and higher hemoglobin (109 vs. 95 g/L, P<0.01). We identified six differentially expressed miRs (let-7a/g/i, miR-200c, miR-1 and miR-30c) that targeted the FGF23/Klotho signaling axis. LVM regressors also demonstrated significantly lower circulating FGF23 levels than LVM progressors [60 (28, 160) vs 668 (73, 1734) pg/mL, P<0.05]. In the angiotensin-II murine model of cardiac hypertrophy, FGF23 gapmer treatment or miR-200c-3p inhibition reduced cardiomyocyte hypertrophy and attenuated interstitial fibrosis while restoring FGF23/Klotho signaling through the suppression of extracellular signal-regulated kinase 1/2 phosphorylation, activation of dual specificity phosphatase-1 and inducing antioxidant gene expression. CONCLUSIONS: Collectively, these exploratory findings link dialysis intensification to miR-mediated regulation of the FGF23/Klotho axis, demonstrating that targeting this regulatory network is sufficient to suppress pathological cardiac remodeling. These data provide a mechanistic basis for the cardiovascular benefits of nocturnal hemodialysis and identify the FGF23/Klotho axis as a candidate therapeutic target warranting further validation.

Clinical Journal of the American Society of Nephrology
University Health Network (CA), Toronto General Hospital (CA), Ted Rogers Centre for Heart Research (CA), Toronto General Hospital Research Institute (CA)
Good health and well-being
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon